Mitoxantrone Hydrochloride

• Catalog No.: Bio-0135
• CAS Number: 70476-82-3
• M. F.: C22H29ClN4O6
• M. W.: 480.94186

SYNONYMS

• IUPAC name: 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-dihydroanthracene-9,10-dione hydrochloride
• IUPAC Traditional name: 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-dihydroanthracene-9,10-dione hydrochloride
• Synonyms: Novantron; Refador; Novatrone; Novantrone; Metrisone; Misostrol

DATABASE IDS

• CAS Number: 70476-82-3

PROPERTIES

• Application(s): Antineoplastic agent against
• Application(s): metastatic breast cancer, acute myeloid leukemia, and non-Hodgkin's lymphoma
• Salt Data: HCl
• Mechanism of Action: DNA intercalator

REFERENCES

• Zee-Cheng, R.K.Y. et al., J. Med. Chem., 1978, 21, 291; 1979, 22, 501, (synth, uv, pharmacol)
• Murdock, K.C. et al., J. Med. Chem., 1979, 22, 1024, (synth, pharmacol)
• Taylor, R.F. et al., J. Chromatogr., 1980, 187, 212, (hplc)
• Henderson, B.M. et al., Cancer Treat. Rep., 1982, 66, 1139, (tox)
• Beijnen, J.H. et al., Anal. Profiles Drug Subst., 1988, 17, 221, (rev)
• Koeller, J. et al., Clin. Pharm., 1988, 7, 574, (rev, pharmacol)
• Ehninger, G. et al., Clin. Pharmacokinet., 1990, 18, 365, (rev, pharmacokinet)
• Faulds, D. et al., Drugs, 1991, 41, 400, (rev)
• Textbook of Adverse Drug Reactions, 4th edn., (ed. Davies, D.M.), Oxford University Press, 1991, (tox)
• Martindale, The Extra Pharmacopoeia, 30th edn., Pharmaceutical Press, 1993, 494
• Catalin, J. et al., Biomed. Chromatogr., 1994, 8, 37, (hplc)
• Panousis, C. et al., Nucleic Acids Res., 1994, 22, 1342, (pharmacol)
• Venitt, S. et al., J. Med. Chem., 1998, 41, 3748-3752, (pharmacol)
• Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, MQY090; MQY100